Bipolar disorder affects 2.4 million adults in the USA between the ages of 18-65 and has considerable economic impact on our society. Bipolar mania accounts for 1 in 7 psychiatric emergencies and is associated with significant morbidity and mortality. The purpose of the study is to evaluate the safety and efficacy of open-label memantine in the acute management of adults with bipolar I disorder hospitalized for mania.
Study Type
INTERVENTIONAL
Purpose
TREATMENT
Masking
NONE
Enrollment
35
Synergy Clinical Research Center
National City, California, United States
Sheppard Pratt Health System
Baltimore, Maryland, United States
St. Charles Psychiatric Associates
Saint Charles, Missouri, United States
Psychiatric Professional Services, Inc.
Cincinnati, Ohio, United States
Young Mania Rating Scale (YMRS)
Mania Rating Scale
Clinical Global Impression
Montgomery Asberg Depression Rating Scale
Positive and Negative Syndrome Scale (PANSS)
PANSS - Excited Component
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Rebecca Sealy Hospital
Galveston, Texas, United States
University Hills Clinical Research
Irving, Texas, United States